Gene · 26524
Papers2,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inactivating LATS2 variation drives tumor progression and resistance to anti-PD-1 therapy in intrahepatic cholangiocarcinoma. | Clin Mol Hepatol | 2026 | 41846519 | PubTator, text mining | PubMed |
| A Cross-Species Hydroquinone Model Replicates Smoking-Related Corneal Endothelial Oxidative Injury and Enables Therapeutic Screening of FGF10. | Invest Ophthalmol Vis Sci | 2026 | 41789845 | PubTator, text mining | PubMed |
| The gut as a central hub for multi-organ crosstalk in aging. | Cell Mol Life Sci | 2026 | 41787017 | PubTator, text mining | PubMed |
| The Hippo pathway in clear cell renal cell carcinoma (ccRCC): a nexus with the VHL disruption? | Transl Oncol | 2026 | 41764979 | PubTator, text mining | PubMed |
| Defining the Active Conformation of Typical Protein Kinase Domains from Substrate-Bound PDB Structures Enables Active-State AlphaFold2 Models for All 437 Human Catalytic Protein Kinases. | bioRxiv | 2026 | 41757035 | PubTator, text mining | PubMed |
| WWC proteins as emerging biomarkers and therapeutic targets in cancer pathogenesis. | Front Cell Dev Biol | 2026 | 41727322 | PubTator, text mining | PubMed |
| Quantifying rate-limiting genetic variation in breast and ovarian tumourigenesis. | EBioMedicine | 2026 | 41724111 | PubTator, text mining | PubMed |
| The harmonies played by miR-302/367 cluster in pluripotency, reprogramming, and rejuvenation. | Stem Cells Transl Med | 2026 | 41693061 | PubTator, text mining | PubMed |
| Targeted gene sequencing and bioinformatics analysis of a patient with gallbladder adenosquamous carcinoma: a case report. | Front Oncol | 2026 | 41669101 | PubTator, text mining | PubMed |
| HCV infection induces ubiquitin-dependent degradation of LATS1, inactivating the Hippo pathway and upregulating transcription of the CYR61 and CTGF genes. | J Gen Virol | 2026 | 41642640 | PubTator, text mining | PubMed |
| Molecular biology of pituitary neuroendocrine tumors. | J Neurooncol | 2026 | 41639477 | PubTator, text mining | PubMed |
| Regulation of tension-dependent localization of LATS1 and LATS2 to adherens junctions. | PLoS One | 2026 | 41628219 | PubTator, text mining | PubMed |
| The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells. | Sci Rep | 2026 | 41577723 | PubTator, text mining | PubMed |
| Identification and Validation of a Prognostic Risk-Scoring Model Based on LATS2 Expression in Acute Myeloid Leukemia. | Cancer Invest | 2026 | 41451824 | PubTator, text mining | PubMed |
| DTX3L promotes renal cell carcinoma progression via ubiquitination and degradation of LATS2. | Cell Signal | 2026 | 41203184 | PubTator, text mining | PubMed |
| FGF2-regulated Osteogenic Differentiation of Human Bone Marrow Stromal Cells. | Curr Stem Cell Res Ther | 2026 | 40734441 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
| Role of FGF2 in promoting osteogenic differentiation for craniofacial bone regeneration. | Regen Eng Transl Med | 2025 | 41583576 | PubTator, text mining | PubMed |
| DistRMI: a deep distance-aware neural network for explainable RNA loop motif-small molecule interaction prediction. | Brief Bioinform | 2025 | 41364671 | PubTator, text mining | PubMed |
| Retraction Note: Circular RNA circ_103820 suppresses lung cancer tumorigenesis by sponging miR-200b-3p to release LATS2 and SOCS6. | Cell Death Dis | 2025 | 41298380 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26524/papers?page=2